Abstract:
Reactive oxygen species (ROS), formed by the partial reduction of oxygen, were for aong time considered to be a byproduct of cellular metabolism. Since, increase in cellular
levels of ROS results in oxidative stress leading to damage of nucleic acids, proteins,
and lipids resulting in numerous pathological conditions; ROS was considered a
bane for aerobic species. Hence, the discovery of NADPH oxidases (NOX), an
enzyme family that specifically generates ROS as its prime product came as a surprise
to redox biologists. NOX family proteins participate in various cellular functions
including cell proliferation and differentiation, regulation of genes and protein
expression, apoptosis, and host defence immunological response. Balanced expression
and activation of NOX with subsequent production of ROS are critically important
to regulate various genes and proteins to maintain homeostasis of the cell.
However, dysregulation of NOX activation leading to enhanced ROS levels is associated
with various pathophysiologies including diabetes, cardiovascular diseases, neurodegenerative
diseases, ageing, atherosclerosis, and cancer. Although our current
knowledge on NOX signifies its importance in the normal functioning of various cellular
pathways; yet the choice of ROS producing enzymes which can tip the scale
from homeostasis toward damage, as mediators of biological functions remain an
oddity. Though the role of NOX in maintaining normal cellular functions is now
deemed essential, yet its dysregulation leading to catastrophic events cannot be
denied. Hence, this review focuses on the involvement of NOX enzymes in various
pathological conditions imploring them as possible targets for therapies.
Significance of the study: The NOXs are multi-subunit enzymes that generate ROS
as a prime product. NOX generated ROS are usually regulated by various molecular
factors and play a vital role in different physiological processes. The dysregulation of
NOX activity is associated with pathological consequences. Recently, the dynamic
proximity of NOX enzymes with different molecular signatures of pathologies has
been studied extensively. It is essential to identify the precise role of NOX machinery
in its niche during the progression of pathology. Although inhibition of NOX could be
a promising approach for therapeutic interventions, it is critical to expand the current
Abbreviations: AP-1, activator protein-1; DUOX, dual oxidase; ERK 1/2, extracellular signal-regulated kinase 1/2; FAD, flavin adenine dinucleotide; JNK, c-Jun N-terminal kinase; MAPK,
mitogen-activated protein kinase; NADPH, nicotinamide-adenine dinucleotide phosphate; NF-êB, nuclear factor kappa B; NOX, NADPH oxidase; PKC, protein kinase C; ROS, reactive oxygen
species; STAT, signal transducer and activator of transcription; TNF-á, tumour necrosis factor alpha.
Received: 2 April 2020 Revised: 18 August 2020 Accepted: 1 September 2020
DOI: 10.1002/cbf.3589
Cell Biochem Funct. 2020;1–17. wileyonlinelibrary.com/journal/cbf © 2020 John Wiley & Sons Ltd 1
understanding of NOX's dynamicity and shed light on their molecular partners and
regulators